Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ovid Therapeutics Inc.

0.3236
+0.00842.66%
Post-market: 0.33260.0090+2.78%19:31 EDT
Volume:246.41K
Turnover:79.77K
Market Cap:23.00M
PE:-0.87
High:0.3295
Open:0.3235
Low:0.3145
Close:0.3152
Loading ...
Mar 16, 2022

Employee Stock Ownership

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Mar 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 15, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 15, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Major Issues Report

8-K - Current report
Nov 10, 2021

Major Issues Report

8-K - Current report
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 07, 2021

Major Issues Report

8-K - Current report
Aug 18, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 16, 2021

Major Issues Report

8-K - Current report
Aug 11, 2021

Major Issues Report

8-K/A [Amend] - Current report
Jul 08, 2021

Major Issues Report

8-K - Current report
Jun 23, 2021

Major Issues Report

8-K - Current report
Jun 11, 2021

Major Issues Report

8-K - Current report